Klotho Therapeutics
Latest round
- Series A
Last raised
- Nov 2017
Total raised
- $10M
Investors
- 1
About Klotho Therapeutics
Founded in 2016 and headquartered in San Diego, US, Klotho Therapeutics, Inc. specializes in the synthetic replication of the Klotho protein, which is crucial for longevity.Klotho Therapeutics (KTI) specializes in the development of a patented Human Klotho Protein aimed at addressing key challenges associated with aging and age-related diseases. The core product involves the synthetic replication of the Klotho protein, which is naturally produced in the kidneys and believed to play a significant role in longevity and overall health. This protein is designed to target various health issues, including cognitive decline, kidney failure, diabetes, and cancer, providing potential therapeutic benefits to patients suffering from these conditions. KTI’s offerings primarily cater to healthcare providers, research institutions, and pharmaceutical companies focusing on aging-related therapies and biomarkers.Klotho Therapeutics generates revenue through partnerships, collaborations, and potential licensing agreements with pharmaceutical companies and research organizations. The company structures its transactions around the development and commercialization of its Klotho protein, targeting both B2B relations with healthcare providers and direct collaborations with research institutions. These transactions are typically structured to facilitate clinical trials, validation of safety and efficacy, and potential future product commercialization. The company aims to broaden its market reach into Europe and Asia by the end of 2024, focusing on partnerships with healthcare providers and research institutions to advance its clinical trials and facilitate the commercialization of its therapeutic solutions.
Who invested in Klotho Therapeutics
1 investor across 1 round
See all investors in Klotho Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 2, 2017
Amount
$10M
Investors
Questions about Klotho Therapeutics
Who invested in Klotho Therapeutics?
Klotho Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Klotho Therapeutics raised?
Klotho Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Klotho Therapeutics last raise money?
Klotho Therapeutics's most recent round on record is a Series A, in Nov 2017.
What does Klotho Therapeutics do?
Founded in 2016 and headquartered in San Diego, US, Klotho Therapeutics, Inc.
Where is Klotho Therapeutics headquartered?
Klotho Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Klotho Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Klotho Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Klotho Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.